Vanja Stevanović

Vanja Stevanović

Auto-generated profile, based on publicly available information

Vanja Stevanović

Institute for Oncology and Radiology of Serbia

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2024 in Oncology Insights
Verified
Journal Article
Open access
VSVanja Stevanović
Vanja Stevanović
MVMiodrag Vukovic
Miodrag Vukovic
JKJelena Kijac
Jelena Kijac
ASAleksandra Stanojevic
Aleksandra Stanojevic
VKValentina Karadžić
Valentina Karadžić
RJRadmila Jankovic
Radmila Jankovic
The T790M mutation in the EGFR gene is a critical biomarker of resistance in patients undergoing EGFR tyrosine kinase inhibitor (TKI) therapy. Accurate and efficient detection of this mutation is essential for guiding treatment decisions in non-small cell lung cancer (NSCLC) patients. This study, conducted over two years at the Institute for Oncology and Radiology of Serbia, compared the effectiveness of digital PCR (dPCR) and quantitative PCR (qPCR) in detecting the EGFR T790M mutation in liquid biopsies of patients with disease progression on EGFR TKIs. Our findings reveal higher detection rate using dPCR (30.48%) compared to qPCR (19.44%). The improved sensitivity of dPCR supports its implementation as a preferred technique for EGFR T790M mutation detection, enhancing clinical decision-making and personalized treatment options for patients with NSCLC.